Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Thiotepa

Client Email

Product

Thiotepa
US Patents

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Thiotepa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 13 USDMF, 1 JDMF, 4 EU WC, 2 KDMF, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

17 API Suppliers
13 USDMF
1 JDMF
4 EU WC
2 KDMF
4 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

39 FDF Dossiers, 21 FDA Orange Book, 7 Europe, 6 Canada, 5 Listed Dossiers

39 FDF Dossiers
21 FDA Orange Book
7 Europe
6 Canada
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 100MG/VIAL, POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 15MG/VIAL

POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 100MG/VIAL
POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL - 15MG/VIAL

DIGITAL CONTENT

8 NEWS #PharmaBuzz

8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 Finished Drug Prices

4 Finished Drug Prices

MARKET PLACE

4 APIs, 6 FDF Dossiers

4 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 2 US Exclusivities

1 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 294,241 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1SHORLA

filter Patent Number Reset all filters

1 All

01 111975013

filter API Patent Reset all filters

1 All

01 1Blank

filter FDF Patent Reset all filters

1 All

01 1Y

filter Expiration Date Reset all filters

1 All

01 12041-08-16

US Patents
US Exclusivities

Product Main Page

01

SHORLA

AAPS 2024

Not Confirmed

SHORLA

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-08-16

US Patent Number : 11975013

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216984

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-08-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?